Literature DB >> 23789227

Effect of electroacupuncture on brain-derived neurotrophic factor mRNA expression in mouse hippocampus following cerebral ischemia-reperfusion injury.

Jianxin Zhao1, Huazhou Xu, Yuanxiang Tian, Manxiang Hu, Hongling Xiao.   

Abstract

OBJECTIVE: This work aims to observe the effects of electroacupuncture on brain-derived neurotrophic factor (BDNF) mRNA expression in mouse hippocampus following cerebral ischemia-reperfusion injury.
METHODS: The models of mouse cerebral ischemia-reperfusion injury were established. A total of 96 healthy mice were randomly assigned into 4 groups, namely, the sham surgery, model, model + electroacupuncture, and mode + hydergine groups. Mice in the model + electroacupuncture group were treated through electroacupuncture at the Shenshu (BL 23), Geshu (BL 17), and Baihui (GV 20) acupoints. Mice in the model+hydergine group were intragastrically administered with hydergine (0.77 mg/kg(-1) x day(-1)). The levels of BDNF mRNA expressions in the hippocampus were ana lyzed through a semi-quantitative reverse transcription-polymerase chain reaction assay on days 1 and 7 after the surgeries.
RESULTS: BDNF mRNA expressions in the mouse hippocampus of the model group on days 1 and 7 after the surgery were higher than those of the sham surgery group (both P < 0.01). On days 1 and 7 of the electroacupuncture treatment, BDNF mRNA expression in the mouse hippocampus of the model + electroacupuncture group was significantly elevated compared with the model group (both P < 0.01) or the model + hydergine group (both P < 0.01). On days 1 and 7 of the hydergine treatment, BDNF mRNA expression in the mouse hippocampus of the model + hydergine group tended to increase compared with the model group; however, statistical significance was not achieved (both P > 0.05).
CONCLUSION: Electroacupuncture treatment enhances endogenous BDNF expression, which may improve the survival environment for intracerebral neurons and inhibit the apoptosis of hippocampal cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23789227     DOI: 10.1016/s0254-6272(13)60135-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  6 in total

1.  Electroacupuncture treatment contributes to the downregulation of neuronal nitric oxide synthase and motoneuron death in injured spinal cords following root avulsion of the brachial plexus.

Authors:  Haoxuan Luo; Xiao Cheng; Ying Tang; Zemin Ling; Lihua Zhou
Journal:  Biomed Rep       Date:  2013-12-12

Review 2.  The neuroprotective role of acupuncture and activation of the BDNF signaling pathway.

Authors:  Dong Lin; Ike De La Pena; Lili Lin; Shu-Feng Zhou; Cesar V Borlongan; Chuanhai Cao
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

3.  Electroacupuncture attenuates cervical spinal cord injury following cerebral ischemia/reperfusion in stroke-prone renovascular hypertensive rats.

Authors:  Feng Tan; Jie Chen; Yangui Liang; Minhua Gu; Yanping Li; Xuewen Wang; DI Meng
Journal:  Exp Ther Med       Date:  2014-03-12       Impact factor: 2.447

4.  Rehabilitation Training and Resveratrol Improve the Recovery of Neurological and Motor Function in Rats after Cerebral Ischemic Injury through the Sirt1 Signaling Pathway.

Authors:  Na Shi; Chongtian Zhu; Liying Li
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

5.  The effect of different frequencies of electroacupuncture on BDNF and NGF expression in the hippocampal CA3 area of the ischemic hemisphere in cerebral ischemic rats.

Authors:  Xiaodong Duan; Lei Zhang; Jihua Yu; Wei Wei; Xi Liu; Fangyuan Xu; Shengmin Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-11       Impact factor: 2.570

6.  Histopathological evaluation of the role of negative electrical charge on renal ischemia/reperfusion injuries on brain and heart tissues in rat.

Authors:  Sara Dehyadegari; Mohammad Mehdi Oloumi; Shahrzad Azizi
Journal:  Vet Res Forum       Date:  2020-03-15       Impact factor: 1.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.